Mangrove Partners’s Healthwell Acquisition Corp. I Class A Common Stock HWEL Stock Holding History

Mangrove Partners’s Portfolio HWEL Stock Details HWEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-450,000	Closed	-$4.46M	–	337
2022 Q4	$4.46M	Buy	450,000 +12,690	+3%	+$125K	0.25%	152
2022 Q3	$4.26M	Buy	437,310 +228,111	+109%	+$2.22M	0.25%	173
2022 Q2	$2.02M	Buy	209,199 +9,199	+5%	+$89.1K	0.1%	296
2022 Q1	$1.94M	Hold	200,000	–	–	0.1%	305
2021 Q4	$1.94M	Buy	+200,000	New	+$1.94M	0.12%	355

Other funds holding HWEL

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return

ACM

Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mangrove Partners's HWEL Position: Q1 2023 in Review

Mangrove Partners sold out of Healthwell Acquisition Corp. I Class A Common Stock (HWEL) in Q1 2023, closing a stake of 450,000 shares — an estimated $4.46M sold.

Mangrove Partners first reported a position in HWEL in Q4 2021 and held it in 5 quarters. The position peaked at $4.46M in Q4 2022. 45 funds tracked by Wall St. Rank hold HWEL as of Q1 2023.

Mangrove Partners reported no remaining Healthwell Acquisition Corp. I Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Mangrove Partners sold 450,000 Healthwell Acquisition Corp. I Class A Common Stock shares in Q1 2023, an estimated $4.46M.
Mangrove Partners first reported a position in Healthwell Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 5 quarters.
Mangrove Partners's Healthwell Acquisition Corp. I Class A Common Stock position peaked at $4.46M in Q4 2022.
45 funds tracked by Wall St. Rank held Healthwell Acquisition Corp. I Class A Common Stock as of Q1 2023.

Based on Mangrove Partners's 13F filing for Q1 2023, filed 15 May 2023.